Renaissance Technologies - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96
-92.3%
30,282
-88.0%
0.00%
-100.0%
Q2 2023$1,252
-40.9%
251,900
-41.2%
0.00%
-33.3%
Q1 2023$2,118
-23.5%
428,700
-2.6%
0.00%
-25.0%
Q4 2022$2,768
-100.0%
440,100
-54.8%
0.00%
-60.0%
Q1 2022$8,880,000
-51.7%
974,700
+38.4%
0.01%
-56.5%
Q2 2021$18,371,000
+480.6%
704,400
+739.6%
0.02%
+666.7%
Q3 2020$3,164,000
+193.2%
83,900
+232.9%
0.00%
+200.0%
Q2 2020$1,079,00025,2000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders